Now days, life is becoming very stressful and fast. As many diseases originate due to this hectic lifestyle. One of the important disease is Hridaroga (Ischemic heart disease), which is responsible for many deaths in early age. In Ayurveda, Hridaroga &amp; their symptoms are described in many textbooks. Management of Hridaroga is also very critical and important. In modern medicine, only expensive interventional procedures are described but on the other hand, Ayurvedic herbs are better, cost effective &amp; good therapeutic option for IHD (Hridaroga).
The review emphasizes on various properties of Terminalia arjuna. Many clinical &amp; animal studies on T.arjuna show its effect on ECG changes, LV functions &amp; myocardial ischaemic reperfusion injury-etc. Besides this it also has antiatherosclerotic, anticoagulant, anti-infarction, hypolipidemic &amp; hypotensive properties. So, Ayurvedic drug (T. arjuna) is a better option for the treatment of IHD (Hridaroga) because it can improve the quality of life in individuals &amp; potentially save millions of lives

G. K., Saxena

Manisha, Dikshit

Puneet Kumar, Garg

English

International Journal of Ayurveda and Pharma Research

 Int. J. Ayur. Pharma Research, 2015;3(2):24-28   ISSN: 2322 - 0910   Available online at : http://ijapr.in Page 24 International Journal of Ayurveda and Pharma Research            Review Article  ROLE OF TERMINALIA ARJUNA IN ISCHEMIC HEART DISEASE (HRIDAROGA): A REVIEW  Dikshit Manisha1*, Garg Puneet Kumar2, Saxena G. K.3  *1Associate Professor, Dept. of Rasa Shastra & Bhaishajya Kalpana, Patanjali Ayurved College, Haridwar, Uttarakhand, India. 2Asst. Prof., Dept. of Rog Nidana & Vikriti Vigyan, Patanjali Ayurved College, Haridwar, Uttarakhand, India. 3Principal, Quadra Institute of Ayurveda, Roorkee. Ex-H.O.D., Dept. of Rasa Shastra & Bhaishajya Kalpana, Rishikul State P.G. Ayurveda College, Haridwar, Uttarakhand, India. Received on: 01/02/2015          Revised on: 13/02/2015                     Accepted on: 24/02/2015   ABSTRACT Now days, life is becoming very stressful and fast. As many diseases originate due to this hectic lifestyle. One of the important disease is Hridaroga (Ischemic heart disease), which is responsible for many deaths in early age. In Ayurveda, Hridaroga & their symptoms are described in many textbooks. Management of Hridaroga is also very critical and important. In modern medicine, only expensive interventional procedures are described but on the other hand, Ayurvedic herbs are better, cost effective & good therapeutic option for IHD (Hridaroga).  The review emphasizes on various properties of Terminalia arjuna. Many clinical & animal studies on T.arjuna show its effect on ECG changes, LV functions & myocardial ischaemic reperfusion injury-etc. Besides this it also has antiatherosclerotic, anticoagulant, anti-infarction, hypolipidemic & hypotensive properties. So, Ayurvedic drug (T. arjuna) is a better option for the treatment of IHD (Hridaroga) because it can improve the quality of life in individuals & potentially save millions of lives. KEYWORDS: Terminalia arjuna, Hridaroga, Ischemic heart disease. INTRODUCTIONToday, in this modern era, Ischemic heart disease (IHD) is a leading cause of morbidity and mortality. This problem is affecting all economic groups of society and also responsible for large number of deaths all over the world. So, IHD is now considered a modern epidemic.1  The main aim of this review article is to explore the scientific basis for the Ayurvedic treatment of IHD with T. arjuna because Ayurvedic substances may provide maximum benefit with cost effectiveness, minimum side effect & increase patient’s compliance. Definition  In Ayurveda, IHD or Hridaroga, is clinically characterized by chest pain produced by increased work load on the heart. The pain starts from sternum and radiates to the left arm, neck and upper part of the abd.2 Nidana (Etiopathogenesis) In Ayurveda, Kapha (atherosclerosis), unhealthy lifestyle, excessive indulgences in sleep, lack of exercise, sedentary habits, eating Kashaya (astringent) & Katu (bitter) food and stress are major causes.3, 4  According to modern, heart suffers from ischemia either due to increased demand or decreased supply. Basically, ischemia is caused by the insufficiency of oxygen and reduced availability of nutrient substrates and inadequate removal of metabolites.5 Bheda (Types)  According to Ayurveda, there are 5 clinical descriptions of Ischemic heart disease (Hridaroga). 1) Vataja, 2) Pittaja, 3) Kaphaja, 4) Tridoshaja, 5) Krimija.6 Complications  According the clinical descriptions of IHD the main complications are angina, myocardial infarction, pulmonary embolism, arrhythmia, fibrillations, pericarditis, cardiogenic shock and sudden ischemic death.7 Dikshit Manisha et al. Role of Terminalia Arjuna in Ischemic Heart Disease (Hridaroga)  Available online at : http://ijapr.in Page 25 Management The main aim of the treatment for all heart diseases is to promote Agni (bio-fire) and to purify the Srotas (channels) by Panchakarma (Mridu sweda, Vamana & Langhana) and use natural herbs that have hypolipedemic & antistress activity. There are many decoctions, medicated ghee, paste & powders for each type of diseases described in Ashtanga Hridaya & other Ayurvedic texts.3,6 The main formulations of T. Arjuna are Kakubhadi choorna, Parthadyarista, Pushayanug choorna, Arjuna ghrit, Arvindasav, Ashwagandharisht, Devdarvyarishta etc.8 Terminalia arjuna All the names of Arjun is mentioned in Bhagavatgita’8.Its bark contains B-citosterol, arjunic acid, arjunetin & fridelin. It also contains cal. Carbonate 34%, salts 9% & tannin 16%. It has Kashaya (astringent) rasa, Laghu & Ruksha guna, Katu vipaka (bitter) sheet (cold) Veerya with Hridya prabhav (cardiac effect).9,1O  Most of the Ayurvedic formulations contain the bark of T. arjuna, one of the most popular herb for the precaution and management of various cardiovascular diseases. The stem bark of this plant is used for medicinal purposes. Properties according to different Samhitas T.arjuna is used in Kaphapittajanya rogas, helps in wound healing, join the bones & heamostatic due to Kashaya (astringent) property. It is cardiotonic, gives strength to cardiac muscles & improves cardiac function & rhythm. It increases peripheral resistance by constricting capillaries which leads to rise in blood pressure. It prevents accumulation of fluid & thereby reduces oedema. It reduces urinary discharges & relieving burning & pain during micturition. It is also effective in diabetes & gonorrhoea. Its bark is used in heart diseases with milk (by Ksheerpaka method).11,12  Scientific basis of T. arjuna  To explore the scientific basis for the use of T. arjuna, many pharmacological and clinical investigations are reviewed. It have been found that these studies include antiatherosclerotic, anti-infarction, anticoagulant & anticholesterol effects of T. arjuna. These all effects are cardioprotective and useful in management of IHD.   Clinical studies  The usefulness of T. arjuna in IHD (Hridaroga) has been confirmed in many clinical studies. It has found to be a mild diuretic without any cardiotonic action, but beneficial. Decoction prepared by its bark showed clinical improvement in patients of CHF (42%), essential hypertension (62%) & cirrhosis of liver (40%), respectively.13  It was further tested in 30 patients of stable angina pectoris. After 1 month, 10% patients did not require sublingual nitrate. ECG improvement was found in terms of reduction in depth of Q-waves & T-waves and changes in ST segment configuration, decrease in heart rate, correction of rhythm disturbance was also noted. A significant reduction in weight was also evident.14  In a study, 500mg of T. arjuna extract was administered twice daily in 25 patients with CAD. After 3 months, reduction in treadmill test response was observed in 6 patients with decrease in frequency of angina attacks and use of sublingual nitrates15. In another study, 500mg T. arjuna was administered twice daily to 20 patients, 15 had stable angina (gr. A) & 5 had unstable angina (gr. B). In both groups, patients experienced increase in LV ejection fraction and reduction in frequency of angina. Treadmill testing on 10 patients of stable angina showed moderate to mild changes after 3 months of therapy.16 In a double blind, crossover design, placebo controlled study, 500 mg of aqueous and alcoholic extract of the bark of T.arjuna was administered for every 8 hr to 12 patients of refractory chronic CHF (NYHA- classic). It was given in addition to maximal tolerable doses of conventional therapy. In this study, T.arjuna as compared with placebo was associated with following improvements- Symptoms and signs of heart failure, Improvement in NYHA classes (class iii), decrease in echo LV end systolic and end diastolic volume-etc. During second phase of study, (means 24 months) further improvement was found in all symptoms.17 In an other double blind placebo controlled study, T.arjuna is compared with ISMN in chronic stable angina patients. 58 patients with evidence of provokable ischaemia on the tread mill exercise test received T. Arjuna 500mg, isosorbide mononitrate 40mg/day or a matching placebo for 1 week. The treatment led to improvement in clinical & treadmill exercise parameters as compared with placebo. These Int. J. Ayur. Pharma Research, 2015;3(2):24-28   ISSN: 2322 - 0910  Available online at : http://ijapr.in Page 26 were similar to those observed with ISMN therapy and the extract was well tolerated.18 The antioxidant and hypocholesterolaemic effects of T.arjuna bark powder was compared with vitamin E, an known antioxidant, in a randomized control trial.105 patients were recruited and separated into three groups using lattin square design. Group 1 received placebo capsules, group 2 received vitamin E cap. (400 units/day) and group 3 received bark of T.arjuna (500 mg/day) in cap. In this study, T.arjuna exhibited a significant antioxidant effect in comparison with vitamin E.19 Animal studies T.arjuna has also been reported to posses hypolipedemic effect in rabbits fed T. arjuna bark for 3 months.20 In another study, rabbits fed bark of T. arjuna with a high cholesterol diet showed lesser increase in total cholesterol and triglycerides.21 The chronic oral administration of T.arjuna also prevented oxidative stress associated with myocardial ischemic reperfusion injury.22 An emulsion of T. Arjuna bark powder (10g/Kg) was given to rabbits orally for seven days. The treatment caused a significant increase in prothrombin time and decrease in platelet count. In a similar study with the alcoholic extract23,24, there was no change in prothrombin time. A water soluble portion of the total alcoholic extract of T.arjuna was found to cause an increase in the force of contraction of a frog heart25. In later studies, both negative and positive ionotropic effects were observed in isolated perfused frog and rabbit hearts and isolated frog and rat Atria26. The extract consists of a mixture of substances capable of exerting both positive and negative ionotropic effects27. The aqueous extract of T.arjuna was also found to produce dose dependent sustained hypotension and bradycardia in dogs28. These observations led the authors to propose that the active constituent in the extract acts centrally.  In another study, it was observed that aortic prostaglandin E2 like activity was enhanced in ischemic rabbit aorta. Pre treated with T.arjuna because PGE2 causes coronary vasodilatation. This may explain the beneficial effect of T.arjuna in patients with coronary artery disease (CAD).29 In a subsequent study, Abana a herbal formula containing T.arjuna significantly increased Creatinine Phophokinase (CPK), Glutamate Oxaloacetate, Transaminase (GOT), Glutamate, Pyruvate, Transaminase (GPT) and Gamma Glutamyl Transpeptidase in serum following myocardial necrosis. The beneficial effect of Abana was further evident form the reduction in mitochondrial enzymes .30 DISCUSSION  In recent years, traditional system of medicine including Ayurveda has been used in the management of IHD. T. arjuna is one of the popular Ayurvedic herb used by many practitioners for the prevention and management of IHD. According to Ayurveda, IHD is the outcome of stressful and sedentary lifestyle with wrong food pattern which leads to ama (i.e. hyperlipedemia) leading to Dhamni pratichaya (thickening of arteries) & Dhamani kathinya (hardening of arteries). The principal treatment is to promote Agni (bio-fire) and to purify all the channels by Panchakarma and to use natural drugs that have cardiotonic, hypolipedemic, anticoagulant and hypotensive properties. In all these studies, T. arjuna showed all these features.  In modern medicine, the treatment of IHD contains expensive interventional procedures, such as thrombolytic therapy and surgical recanalization. So, T. arjuna and other Ayurvedic herbs and drugs are best cost effective and acceptable therapeutic option for IHD.  The current review showed that T. arjuna provided relief in angina and its effect on ST segment changes & T-wave depression in IHD. There is no known side effect of this conventional therapy. CONCLUSION 1. IHD is the outcome of sedentary lifestyle & faulty diet. 2. The principle treatment is to promote Agni (biofire) & to purify the channels (Srotas). 3. In the treatment of Hridroga, natural drugs should have cardiotonic, hypotensive, hypolipidaemic and haemostatic properties. 4. In modern, the treatment involves expensive interventional procedures but T.arjuna shows better & cost effective treatment. 5. The studies on T.arjuna shown improvement in LV function, ECG changes, decrease in prothrombin time, hypocholesterolaemic effect etc. 6. The widespread use of T.arjuna shows decrease in mortality rate by conventional treatment& improves quality of life.    Dikshit Manisha et al. Role of Terminalia Arjuna in Ischemic Heart Disease (Hridaroga)  Available online at : http://ijapr.in Page 27 REFERENCES 1. Pedoe H.T. Ischemic Heart Diseases in Epidomology of Diseases. Miller, D.L., Farmer R.T.D. editors. Oxford: Blackwell; 1982. 2. Tortora J. Gerard, Gorabowski, Sandra Reynolds. Principles of Anatomy and Physiology.7ed.Harper Collins Colleague publication; 1992. P.591. 3. Maharshi Agnivesh. Charaka Chikitsa edited by Shastri Kashinath, Chaturvedi Gorakhnath. 22 ed. Varanasi:Chaukhamba Vishwa Bharti;1996. Ch26, P.731. 4. Maharshi Susruta. Susruta Samhita (Uttarardha) edited by Shastri Ambika Dutt. 10 ed. Varanasi: Chakhamba Sanskrit Sansthan;1996. Ch43, P.277. 5. Kumar Vinay, Cotran S. Ramzi, Robbins L. Stanley. Basic Pathology. 15 ed. Bangalore: Prism Books Pvt. Ltd;1992. Ch11, P.307. 6. Acharya Vagbhatta. Astanga Hridayam (Chikitsa Sthan) edited by Upadhyay Yadunanadan. Re ed. Varanasi:Chaukhamba Sanskrit Sansthan; 2006. Ch6, P.328. 7. Davidson. Principles & Practice of Medicine edited by Edwards R.W., Bouchier I.A.D., Haslett C., Chilvers E.R. 17 ed. Churchill Livingstone Pub; 1995.P205,208,212,245. 8. Gote VM. Ayurvedic Pharmacology and Therapeutic uses of medicinal plants (Dravyagun Vigyan). Reprint. New Delhi: Chaukhamba Pub;2009. P.299. 9. Sharma P.V. Dravya Guna Vigyana (Vol II). 17 ed. Varanasi: Chaukhamba Bharti Academy; 1996. P. 195. 10. Dhanvantari Nighantu edited by Ojha J, Mishra Umapati. Reprint. Varansi: Chaukhamba Vidyabhawan;2004.P.225. 11. Bhav Mishra. Bhavprakash Nighantu edited by Chunekar KC. Reprint. Varanasi: Chaukhamba Vishwabharti;2010.P.511. 12. Kaidev Nighantu edited by Sharma PV, Sharma GP. Reprint. Varanasi: Chaukhamba Orientalia; 2009. P.153. 13. Colabawalla H.M. An Evaluation of the Cardotonic & other properties of Terminalia Arjuna, Indian Heart. 1951.3:205. 14. Dwivedi S & Udupa N. T.arjuana: Pharmacognosy, Phytochemistry, Pharmacology and clinical use: A review. Phytoterapia 1989. 60:413. 15. Jain V, Poonia A, Agrawal RP, Panwar, RB, Kochar DK & Mishra SN. Effect of T. Arjuna in Patients of Angina Pectoris (a clinical trial) . Indian Med. Gazette (New Series).1992. 36: 56. 16. Dwivedi S & Agrawal MP, Antifungal Cardioprotective effects of T. Arjuna, an indigenous drug in Coronary Artery disease. Journal: Association Physicians, India. 1994. 42:287. 17. Bharani A, Ganguly A, Bhargav KD. Salutary of T.arjuna in patients with severe refractory heart failure. Indian J. Cardiol.1995.49:191. 18. Bharani A, Ganguly A, Mathur LK, Jamra Y, Raman PG. Efficacy of T.arjuna in chronic stable angina: a doubleblind, placebo controlled, crossover studycomparing T.arjuna with isosorbide mononitrate. Indian Heart J.:2002.54:170. 19. Gupta R, Singhal S, Goyal A, Sharma VN. Antioxidant and Hypocholesterolaemic effects of T.arjuna tree bark powder:a randomized placebo controlled trial. J. Assn. Physicans India:2001.49:231. 20.  Dwivedi S, Somany PN, Chansouria JPN, Udupa KN. Cardioprotective effects of certain indigenous drugs in Myocardial Ischemia in rabbits. Indian J. exp biol. 1988. 26:969. 21. Tiwari A.K. Gode J.D. and Dubey G.P.Effect of T.Arjuna on Lipid Profiles of Rabbit fed hyperchloesterolemic diet.Int. J.Crude drug Res. 1990. 28:43. 22. Gauthaman K, Maulik M, Kumari R, Manchanda SC, Dinda AK & Maulik SK. Effect of Chronic Treatment with bark of T. Arjuna: a study on the isolated ischaemic reperfused rat heart. Ethanopharmacol. 2001. 75:197. 23. Chaturvedi PN. A study on the Effect of an Indigenous Drug Arjuna (Terminalia arjuna W&A) on arterial thrombosis and ischaemic heart disease, thesis(Doctor of Ayurvedic Medicine), Banaras Hindu University, Varanasi, UP India, 1967. 24. Gupta LP, Sen SP, Udupa KN. Pharmacognostical and Pharmacological studies on T.arjuna. J.Res. Indian Med. Yoga Homeopathy.1976.11:16. 25. Gupta LP. Studies on Cardiac Muscle Regeneration under the Influence of Certain Indigenous Drugs, Ph.D.thesis, Banaras Hindu University.Varanasi:1974.  26. Srivastava RD, Dwivedi S, Sreenivasan KK and Chandrashekhar CN, Cardiovascular effects of Terminalia species of plants.Indian Drugs. 1992.29:144. 27. Karamsetty M, Ferrie TJ, Kane KA, Gray AI. Effects of an aqueous extract of Terminalia arjuna on isolated rat and thoracic aorta, Phytothrapy Res. 1995. 9:575. Int. J. Ayur. Pharma Research, 2015;3(2):24-28   ISSN: 2322 - 0910  Available online at : http://ijapr.in Page 28 28. Singh N, Kapur KK, Singh SP, Shankar K, Sinha JN and Kohli RP, Mechanism of Cardiovascular action of T.arjuna, Planta Medica.1982.45:102. 29. Dwivedi S, Chansouria JPN, Somani PN &Udupa KN. Influence of certain Indigenous drugs on the PGE-Like activity in the ischemic rabbit aorta, Indian Drugs.1987.24:378. 30. Tandon S, Rastogi R and Kapoor NK, Protection by abana: a herbomineral preparation, against myocardial necrosis in rats induced by isoproterenol, Phytotherapy Res.1995. 10:263.       Cite this article as:  Dikshit Manisha, Garg Puneet Kumar, Saxena G. K. Role of Terminalia Arjuna in Ischemic Heart Disease (Hridaroga): A Review. Int. J. Ayur. Pharma Research. 2015;3(2):24-28. Source of support: Nil, Conflict of interest: None Declared  *Address for correspondence Dr. Manisha Dikshit  Associate Professor Dept. of Rasa Shastra & Bhaishajya Kalpana, Patanjali Ayurved College, Haridwar, Uttarakhand, India  Email: miti.manisha@gmail.com   Ph: +919412367572    

ROLE OF TERMINALIA ARJUNA IN ISCHEMIC HEART DISEASE (HRIDAROGA): A REVIEW

https://ijapr.in/index.php/ijapr/article/download/159/143

ROLE OF TERMINALIA ARJUNA IN ISCHEMIC HEART DISEASE (HRIDAROGA): A REVIEW

Abstract

Similar works

Full text

Available Versions

International Journal of Ayurveda and Pharma Research